Latest Rare Disease News News
ChemoCentryx’s Avacopan Scores European Approval For ANCA
The European Union has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) for…
SpringWorks Therapeutics Announces Abstracts Accepted for
– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted…
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted…
Rosie O’Donnell: I’m married, selling art on eBay
LOS ANGELES (AP) — Rosie O’Donnell has announced that she married her…
In Conversation: Virginie Bros-Facer and Avril Daly on the future at 02xl
Home \ Newsroom \ News \ In Conversation: Virginie Bros-Facer and Avril…
AI tool helps predicts patient responses to cancer drugs
Researchers have used high-resolution gene expression data from individual tumor cells to…
Charting the Future: Valentina Bottarelli on Shaping an EU Action Plan for Rare Diseases
Home \ Newsroom \ Staff Blog \ Charting the Future: Valentina Bottarelli…
JARDIN 101: The Purpose. The Plan. The Potential.
JARDIN 101: The Purpose. The Plan. The Potential.April 2024 Rare diseases pose…